CBD in France: dietary supplement controls underway

The sale of dietary supplements containing CBD is subject to unclear regulations, tolerated but not authorized. However, dietary supplements must under no circumstances make therapeutic claims, which could lead to sanctions by the French authorities. The Direction Générale de la Concurrence, de la Consommation et de la Répression des Fraudes (DGCCRF) and the Direction Générale de l'Alimentation (DGAL ) have recently launched joint controls to verify compliance with these regulations.

It's important to point out that some market players have always been concerned about the correct classification of products and compliance with the Novel Food law, such as our company, Swiss Medical Cannabis S.A. Our company, which has been in business for seven years, has always taken the protection of consumers and professionals to heart, and considered its CBD oils to be cosmetic products and not dietary supplements in order to comply with regulations. It has never claimed therapeutic properties on its packaging, nor recommended potentially therapeutic dosages.

It's also essential to note that CBD can interact with certain medications, and it's advisable to take precautions if consumed in combination with them. To find out more about interactions between CBD and medicines, Swiss Medical Cannabis S.A offers a dedicated article on its website:

Now, more than ever, all market players need to be aware of their responsibilities and comply with current regulations to ensure a healthy, sustainable CBD market.

DGCCRF launches controls on CBD products: https://www.newsweed.fr/dgccrf-controles-produits-cbd/